Page last updated: 2024-08-26

sr141716 and Movement Disorders

sr141716 has been researched along with Movement Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grel, A; Metna-Laurent, M; Mondésir, M; Piazza, PV; Vallée, M1
Adrian, R; Baratta, J; Giuffrida, A; Piomelli, D; Solbrig, MV1

Other Studies

2 other study(ies) available for sr141716 and Movement Disorders

ArticleYear
Cannabinoid-Induced Tetrad in Mice.
    Current protocols in neuroscience, 2017, Jul-05, Volume: 80

    Topics: Animals; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Catalepsy; Disease Models, Animal; Dronabinol; Exploratory Behavior; Hypothermia; Male; Mice; Mice, Inbred C57BL; Movement Disorders; Piperidines; Pyrazoles; Rimonabant

2017
A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena.
    Experimental neurology, 2005, Volume: 194, Issue:2

    Topics: Animals; Anticonvulsants; Arachidonic Acids; Basal Ganglia; Borna Disease; Cannabinoid Receptor Modulators; Convulsants; Disease Models, Animal; Endocannabinoids; Limbic System; Male; Movement Disorders; Naloxone; Narcotic Antagonists; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Inbred Lew; Receptor, Cannabinoid, CB1; Rimonabant; Seizures

2005